or Try an Advanced Search...

    Technical Analysis for ICU - SeaStar Medical Holding Corporation

    Grade Last Price % Change Price Change
    F 0.44 7.60% 0.03
    ICU closed up 7.6 percent on Monday, April 22, 2024, on 45 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 14
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ICU trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Below Lower BB Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion 7.60%
    Older End-of-Day Signals for ICU ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 14 hours ago
    Possible Inside Day about 14 hours ago
    Gap Up Partially Closed about 18 hours ago
    60 Minute Opening Range Breakout about 18 hours ago
    Rose Above Lower Bollinger Band about 18 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ICU Chart by TradingView
    Basic chart:

    Profile

    SeaStar Medical Holding Corporation, a medical device company, develops cytopheresis systems for addressing inflammation-based diseases and conditions. The company focuses on acute renal failure, end-stage renal disease, and acute inflammation induced by cardiopulmonary bypass surgery. It develops products based on the configurations of commercially available hollow fiber dialysis filters that are used in a proprietary manner to sequester and deactivate leukocytes in the patient's blood system. The company was founded in 1994 and is based in Denver, Colorado.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Inflammation Kidney Disease Dialysis End Stage Renal Disease Kidney Nephrology Organ Failure Acute Kidney Injury Kidney Failure Cardiopulmonary Bypass Surgery

    Is ICU a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 17 SeaStar Medical Holding GAAP EPS of -$1.21 misses by $0.60
    Apr 17 SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
    Mar 27 SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
    Mar 12 SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients
    Mar 11 SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024
    Mar 6 Q4 2023 Nuwellis Inc Earnings Call
    Mar 4 Peering Into SeaStar Medical Holding's Recent Short Interest
    Feb 27 Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure
    Feb 22 Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™
    Feb 22 FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury
    See more ICU news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.2799
    52 Week Low 0.162
    Average Volume 5,917,228
    200-Day Moving Average 0.58
    50-Day Moving Average 0.80
    20-Day Moving Average 0.68
    10-Day Moving Average 0.62
    Average True Range 0.10
    RSI (14) 32.43
    ADX 15.22
    +DI 15.72
    -DI 31.81
    Chandelier Exit (Long, 3 ATRs) 0.54
    Chandelier Exit (Short, 3 ATRs) 0.67
    Upper Bollinger Bands 0.88
    Lower Bollinger Band 0.47
    Percent B (%b) -0.1
    BandWidth 59.82
    MACD Line -0.07
    MACD Signal Line -0.05
    MACD Histogram -0.0265
    Fundamentals Value
    Market Cap 28.39 Million
    Num Shares 65.1 Million
    EPS -1.31
    Price-to-Earnings (P/E) Ratio -0.33
    Price-to-Sales 0.00
    Price-to-Book 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.52
    Resistance 3 (R3) 0.53 0.50 0.51
    Resistance 2 (R2) 0.50 0.48 0.50 0.50
    Resistance 1 (R1) 0.47 0.47 0.49 0.46 0.50
    Pivot Point 0.45 0.45 0.45 0.44 0.45
    Support 1 (S1) 0.41 0.42 0.43 0.41 0.37
    Support 2 (S2) 0.39 0.41 0.39 0.37
    Support 3 (S3) 0.35 0.39 0.36
    Support 4 (S4) 0.35